课题基金 / 基金详情

CaMKII activation and regulation in adult cardiac myocytes

CaMKII activation and regulation in adult cardiac myocytes
成人心肌细胞中 CaMKII 的激活和调节
批准号:
10687251
负责人:
Donald M Bers
金额:
$72.12万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-04-18 至 2026-06-30

项目摘要

项目成果

Donald M Bers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/ Abstract Ca-Calmodulin dependent protein kinase (CaMKII) is an important regulator of cardiac function, and dysfunction in pathological states, regulating ion channels, Ca transporters, myofilaments and nuclear transcription. CaMKII may normally fine-tune these processes. But in pathological conditions like heart failure (HF), chronic autonomous CaMKII activation can over-phosphorylate targets, contributing to arrhythmogenesis due to acute effects on several ion channels and Ca- handling proteins. Chronic CaMKII activation is also a hallmark of several pathological states and acute or genetic CaMKII inhibition can reduce arrhythmias and the progression of HF. Thus understanding fundamental aspects of CaMKII regulation in cardiac myocytes is critical understanding dysfunction and potential therapeutics. We and others discovered several novel post-translational modifications (PTMs) that can trap CaMKII in an activated state, rather than turning on & off rapidly with local Ca transients. Autophosphorylation, oxidation, GlcNAcylation and S-nitrosylation within a regulatory hotspot on CaMKII creates memory and autonomous activity, even when Ca/CaM falls. There are also 3 PTMs at other sites that suppress CaMKII activation. Aims 1 and 2 will directly measure how these PTMs differentially affect activation and memory of CaMKII in adult cardiac myocytes, to fill a major knowledge gap in this field. Aim 3 will test whether CaMKII S-nitrosylation at a single site is required for the heart’s intrinsic response to increase Ca transients and contraction in response to acute and chronic pressure overload (or the Anrep effect). CaMKII has well-recognized roles in HF with reduced ejection (HFrEF), but its role in HF with preserved ejection (HFpEF) is unclear. Aim 4 will directly test the engagement of CaMKII in two new HFpEF models. The proposed studies will have major impact on our understanding of how CaMKII activity is regulated in heart, in ways that promote pathology and might be targets for therapeutic intervention.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Neuron-Restrictive Silencer Factor Limits Myocyte GαO Expression and Is Protective in Heart Failure Progression.
神经元限制性沉默因子限制肌细胞 GαO 表达并在心力衰竭进展中具有保护作用。
DOI: 10.1161/circresaha.121.320597
发表时间: 2022
期刊: Circulation research
影响因子: 20.1
作者: [Sossalla,Samuel, Bers,DonaldM]
通讯作者: Bers,DonaldM
DOI: 10.1016/j.yjmcc.2018.10.010
发表时间: 2018-12
期刊: Journal of molecular and cellular cardiology
影响因子: 5
作者: [Wood BM, Simon M, Galice S, Alim CC, Ferrero M, Pinna NN, Bers DM, Bossuyt J]
通讯作者: Bossuyt J
CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.
CaMKII 和 PKA 依赖性磷酸化共同调节成体心肌细胞中 HDAC4 的核定位。
DOI: 10.1007/s00395-021-00850-2
发表时间: 2021-02-15
期刊: Basic research in cardiology
影响因子: 9.5
作者: [Helmstadter KG, Ljubojevic-Holzer S, Wood BM, Taheri KD, Sedej S, Erickson JR, Bossuyt J, Bers DM]
通讯作者: Bers DM
DOI: 10.1126/sciadv.abg0927
发表时间: 2021-11-19
期刊: Science advances
影响因子: 13.6
作者: [Morotti S, Liu C, Hegyi B, Ni H, Fogli Iseppe A, Wang L, Pritoni M, Ripplinger CM, Bers DM, Edwards AG, Grandi E]
通讯作者: Grandi E
6
    Training Program in Pharmacology
    Systems Approach to Understanding Cardiovascular Disease and Arrhythmias - Cell diversity in the cardiovascular system, cell-autonomous and cell-cell signaling
    Project 2 (Bers)
    • 批准号:
      10677715
    • 项目类别:
    • 资助金额:
      $74.77万
    • 财政年份:
      2019
    • 负责人:
      Donald M Bers
    • 依托单位:
    Systems Approach to Understanding Cardiac Arrhythmias Mechanisms
    海外基金